PAREXEL International Corp. has completed the acquisition of Taiwan-based APEX International Clinical Research Co., Ltd. for approximately $51 million. The acquisition adds to PAREXEL’s clinical research service offerings in the Asia-Pacific region, including China, Hong Kong, India, Taiwan, Singapore, Indonesia, South Korea, Malaysia, Thailand, the Philippines, New Zealand, and Australia. The name of the new entity is PAREXEL APEX International. “The Asia-Pacific region is beco...